Epix makes management moves

MRI contrast developer Epix Pharmaceuticals reported that Peyton Marshall, its chief financial officer and senior vice president of finance and administration, has resigned his position to pursue other interests.

Epix also announced the promotion of Robert Pelletier, currently the company's senior director of finance, to the position of principal accounting officer and executive director of finance, according to the Cambridge, MA-based firm.

By AuntMinnie.com staff writers
July 6, 2005

Related Reading

Epix's Vasovist moves closer to market, July 1, 2005

Epix submits response to FDA, May 23, 2005

Epix revenues, income down in Q1, April 29, 2005

Epix launches blood-clot agent trial, April 7, 2005

Epix signs DeWitt, April 5, 2005

Copyright © 2005 AuntMinnie.com

Page 1 of 605
Next Page